EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review

Natasha Cordeiro Dos Santos, Marc Miravitlles, Aquiles Assunção Camelier, Victor Durier Cavalcanti de Almeida, Roberto Rodrigues Bandeira Tosta Maciel, Fernanda Warken Rosa Camelier

Tuberculosis and Respiratory Diseases · 01.07.2022 · 85 (3) · 205-220

DOI: 10.4046/trd.2021.0179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Tuberculosis and Respiratory Diseases, erschienen am 01.07.2022. Verfasst von Natasha Cordeiro Dos Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, State University of Bahia (UNEB), Bahia, Brazil. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Bahia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A systematic review based on the PRISMA methodology was performed from January 2020 until July 2021. The MEDLINE, Lilacs, and Scielo databases were searched to identify studies related to COPD and its comorbidities. Observational studies on the prevalence of comorbidities in COPD patients and costs with health estimates, reduced quality of life, and mortality were included. Studies that were restricted to one or more COPD pain assessments and only specific comorbidities such as osteoporosis, bronchitis, and asthma were excluded. The initial search identified 1,409 studies and after applying the inclusion and exclusion criteria, 20 studies were finally selected for analysis (comprising data from 447,459 COPD subjects). The most frequent COPD comorbidities were: hypertension (range, 17%–64.7%), coronary artery disease (19.9%–47.8%), diabetes (10.2%–45%), osteoarthritis (18%–43.8%), psychiatric conditions (12.1%–33%), and asthma (14.7%–32.5%). Several comorbidities had an impact on the frequency and severity of COPD exacerbations, quality of life, and mortality risk, in particular malignancies, coronary artery disease, chronic heart failure, and cardiac arrhythmias. Comorbidities, especially cardiovascular diseases and diabetes, are frequent in COPD patients, and some of them are associated with higher mortality.

Schlagwörter

Stichwörter der Autor:innen

COPDComorbidityHealthCare XostsHospitalizationMortalitySeverity

Autor:innen und Institutionen

  • Department of Life Sciences, State University of Bahia (UNEB), Bahia, Brazil.
  • Department of Pneumology, Hospital Vall d'Hebron/Vall d'Hebron Research institute (VHIR), Barcelona, Spain.

Förderung

  • University of Bahia

Zitieren

APA

Santos, N. C. D., Miravitlles, M., Camelier, A. A., Almeida, V. D. C., Maciel, R. R. B. T., & Camelier, F. W. R. (2022). Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberculosis and Respiratory Diseases, 85(3), 205-220. https://doi.org/10.4046/trd.2021.0179

Vancouver

Santos NCD, Miravitlles M, Camelier AA, Almeida VDC, Maciel RRBT, Camelier FWR. Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberculosis and Respiratory Diseases. 2022;85(3):205-220. doi:10.4046/trd.2021.0179

BibTeX
@article{Santos2022,
  author = {Santos, Natasha Cordeiro Dos and Miravitlles, Marc and Camelier, Aquiles Assunção and Almeida, Victor Durier Cavalcanti de and Maciel, Roberto Rodrigues Bandeira Tosta and Camelier, Fernanda Warken Rosa},
  title = {Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review},
  journal = {Tuberculosis and Respiratory Diseases},
  year = {2022},
  volume = {85},
  number = {3},
  pages = {205--220},
  doi = {10.4046/trd.2021.0179}
}
Kostenlos starten →